Treatment of epistaxis in hereditary hemorrhagic telangiectasia patients by argon plasma coagulation with local anesthesia

American Journal of Rhinology

Volumn 20, Issue 4, 2006, Pages 421-425

  Pagella, Fabio ^a   Semino, Lucia ^a   Olivieri, Carla ^a   Corno, Sabrina ^a   Dore, Roberto ^b   Draghi, Ferdinando ^b   Lanzarini, Luca ^b   Vespro, Valentina ^b   Buscarini, Elisabetta ^c   Danesino, Cesare ^a,b  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c MAGGIORE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MIDAZOLAM; XYLOMETAZOLINE;

ADULT; AGED; ARGON PLASMA COAGULATION; ARTERY LIGATION; ARTICLE; BLOOD TRANSFUSION; CAUTERIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; EPISTAXIS; FEMALE; HEALTH CARE COST; HUMAN; LASER SURGERY; LOCAL ANESTHESIA; MALE; NOSE SEPTUM RECONSTRUCTION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RENDU OSLER WEBER DISEASE;

ADULT; AGED; ANESTHESIA, LOCAL; ARGON; BLOOD COAGULATION; EPISTAXIS; FEMALE; HUMANS; MALE; MIDDLE AGED; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; TREATMENT OUTCOME;

EID: 33748688628     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/ajr.2006.20.2886     Document Type: Article

References (23)

1. Porteous MEM, Burns J, and Proctor SJ. Hereditary haemorrhagic telangiectasia: A clinical analysis. J Med Genet 29: 527-530, 1992.
2. Azuma H. Genetic and molecular pathogenesis of hereditary hemorrhagic telangiectasia. J Med Invest 47:81-90, 2000.
3. Plauchu H, de Chadarevian JP, Bideau A, et al. Age related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 32:291-297, 1989.
4. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Genet 91:66-67, 2000.
5. Haitjema T, Balder W, Disch FJM, et al. Epistaxis in hereditary hemorrhagic telangiectasia. Rhinology 34:176-178, 1996.
6. Jahnke V. Ultrastructure of hereditary telangiectasia. Arch Otolaryngol 91:262-265, 1970.
7. Lund VJ, and Howard DJ. A treatment algorithm for the management of epistaxis in hereditary hemorrhagic telangiectasia. Am J Rhinol 13:319-322, 1999.
8. Aassar OS, Friedman CM, and White RI. The natural history of epistaxis in hereditary hemorrhagic telangiectasia. Laryngoscope 101:977-980, 1991.
9. McCaffrey TV, Kern EB, and Lake CF. Management of epistaxis in hereditary hemorrhagic telangiectasia. Review of 80 cases. Arch Otolaryngol 103:627-630, 1977.
10. Harrison DFN. Use of estrogen in treatment of familial hemorrhagic telangiectasia. Laryngoscope 92:314-319, 1982.
11. Bergler W, Riedel F, Baker-Schreyer A, et al. Argon Plasma coagulation for the treatment of hereditary hemorrhagic telangiectasia. Laryngoscope 109:15-20, 1999.
12. Stankiewicz JA. Nasal endoscopy and control of epistaxis. Curr Opin Otolaryngol Head Neck Surg 12:43-45, 2004.
13. Rebeiz EE, Park S, and Shapshay SM. Treatment of hereditary hemorrhagic telangiectasia with Neodymium: Yttrium-Aluminum-Garnet laser photocoagulation. Oper Tech Otolaryngol Head Neck Surg 2:177-182, 1991.
14. Lennox PA, Hitchings AE, Lund VJ, et al. The SF-36 health status questionnaire in assessing patients with epistaxis secondary to hereditary hemorrhagic telangiectasia. Am J Rhinol 19:71-74, 2005.
15. Shah RK, Dhingra JK, and Shapshay SM. Hereditary hemorrhagic telangiectasia: A review of 76 cases. Laryngoscope 112:767-773, 2002.
16. Siegel MB, Keane WM, Atkins JP, et al. Control of epistaxis in patients with hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck Surg 105:675-679, 1991.
17. Saunders WH. Septal dermoplasty for control of nose bleeds in hereditary haemorrhagic telangiectasia. Trans Am Acad Ophthalmol Otolaryngol 64:500-506, 1960.
18. Mc Cabe WP, and Kelly AP. Management of epistaxis in Osler-Rendu-Weber disease. Recurrence of telangetases within a nasal skin graft. Plast Reconstr Surg 50:114-118, 1972.
19. Rebeiz EE, Bryan DJ, Ehrlichman RJ, et al. Surgical management of life-threatening epistaxis in Osler-Weber-Rendu disease. Ann Plast Surg 35:208-213, 1995.
20. Elden L, Montanera W, Terbrugge K, et al. Angiographic embolization for the treatment of epistaxis: A review of 108 cases. Otolaryngol Head Neck Surg 111:44-50, 1994.
21. Young A. Closure of nostrils in atrophic rhinitis. J Laryngol Otol 81:515-524, 1967.
22. Lund VJ, and Howard DJ. Closure of the nasal cavities in the treatment of refractory hereditary haemorrhagic telangiectasia. J Laryngol Otol 111:30-33, 1996.
23. Hitchings AE, Lennox PA, Lund VJ, et al. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia. Am J Rhinol 19:75-78, 2005.